Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
to emerging or re-emerging diseases. Proficiency in programming languages such as Python, R, SQL, or similar tools for data analysis and model development. Experience in working with large and complex datasets
-
. Proficiency in Python for data analysis and model development (NumPy, pandas, scikit-learn). Working knowledge of SQL and relational databases. Familiarity with at least one ML or deep learning framework (e.g
-
sampling grids, analyze temporal trends, and produce visualizations and reports to support cannabis remediation research on tribal lands. Minimum Qualifications Knowledge of spatial statistics, GIS analysis
-
genomics data, writing Python code for data analysis, and a downstream R pipeline for post-processing data using standard Bioinformatics libraries from Bioconductor. There will be opportunities
-
architectures (e.g., convolutional neural networks or transformers); deep specialization is not required. Exposure to Generative AI concepts and large language models (LLMs) is a plus. Proficiency in Python
-
human expert ratings. ESSENTIAL QUALIFICATIONS Graduate student or professional in Computer Science, Data Science, Computational Linguistics, or related field Strong Python programming skills (pandas
-
in bioinformatics or genomic data analysis, and possess strong programming skills in languages commonly used in bioinformatics, such as Python and R. Candidates should also have experience with genomic
-
Systems, Quantum AI, Blockchain AI, AI for Autonomous Systems Foundational courses (for Connect pathway students): Python programming, Mathematical Concepts, Research Methods and Scientific Writing
-
willing to receive assistance and coaching when needed from the faculty lead. Prior experience in a diverse higher education institution preferred. Knowledge of Python and/or R programming languages is
-
Pharmaceuticals is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases. Ironwood is advancing apraglutide, a next-generation